Exact Sciences (NASDAQ: EXAS) reported Q1 EPS of ($0.49), $0.03 better than the analyst estimate of ($0.52). Revenue for the quarter came in at $14.8 million versus the consensus estimate of $14.83 million.

For earnings history and earnings-related data on Exact Sciences (EXAS) click here.